The Helmholtz Centre for Infection Research (HZI) is organised in the form or a GmbH (equals “Ltd.”). Shareholders are the Federal Republic of Germany (90%) and the federal states Lower-Saxony (9%) and Saarland (1%).
Representatives from the shareholders are members of the supervisory board – together with experts from universities, clinics, economy, other research institutes and from the HZI itself. The highest governing body of the HZI meets twice a year, it takes the major policy decisions and appoints the two directors. The scientific committee advices the supervisory board. The middle management of the centre is composed of the heads of academic departments, administrative units and staff units.
The Supervisory Board oversees the legality, expedience and economy of the management. It decides on general research goals, the principal research policy and financial affairs of the centre. It consists of a maximum of 15 members.
Members of the Supervisory Board
MinDir'in Bärbel Brumme-Bothe, Federal Ministry of Education and Research
Rüdiger Eichel, Ministry for Science and Culture of Lower Saxony
Prof. Dr. Christopher Baum, Hannover Medical School
Prof. Dr. Jan Buer, Essen University Hospital
Prof. Dr. Petra Dersch, Helmholtz Centre for Infection Research
Prof. Dr. Petra Gastmeier, Charité - Universitätsmedizin
Prof. Dr. Jörg Hacker, Leopoldina - German Academy of Sciences
Prof. Dr. Wolf-Dietrich Hardt, Swiss Federal Institute of Technology Zurich
Prof. Dr. Caroline Kisker, Julius-Maximilian University of Würzburg
Prof. Dr. Christine Lang, ORGANOBALANCE GmbH
Christian Mees, Saarland - Staatskanzlei
Dr. Siegfried Weiß, Helmholtz Centre for Infection Research